Correction to: Management of Patients with Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide, Exenatide ER, Liraglutide and Lixisenatide: A Cost-Effectiveness Analysis in the Danish Setting
Gæde, Peter, Johansen, Pierre, Tikkanen, Christian Klyver, Pollock, Richard Fulton, Hunt, Barnaby, Malkin, Samuel Joseph PaulLanguage:
english
Journal:
Diabetes Therapy
DOI:
10.1007/s13300-019-0638-y
Date:
May, 2019
File:
PDF, 450 KB
english, 2019